chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass, Swelling
Clinical narrative: Swelling in neck area; lump on left side of neck.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 12Apr2021 at 10:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 22Mar2021 at 09:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 07:00, the patient experienced swelling in neck area and a medium size lump on left side of neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events swelling in neck area and a medium size lump on left side of neck was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Mass
Clinical narrative: Squishy lump on collarbone; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 12Apr2021 at 14:30 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies. The patient did not receive any concomitant medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 06:30, the patient experienced squishy lump on collarbone. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of these events.  The clinical outcome of the event squishy lump on collarbone was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Myalgia
Clinical narrative: Headache; Nausea; Muscle aches; Chills; Tiredness; Joint pain; Injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153), via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included blood pressure high, acid reflux and seasonal allergies. Concomitant medications included calcium citrate (CITRACAL), hydrochlorothiazide (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the right arm on 21Mar2021 at 11:45 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and tetracycline (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced headache, nausea, muscle aches, chills, tiredness, joint pain and injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of headache, nausea, muscle aches, chills, tiredness, joint pain and injection site pain were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: Headache; Nausea; Muscle aches; Chills; Tiredness; Joint pain; Injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153), via an unspecified route of administration in the left arm on 08Apr2021 at 12:00 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Medical history included blood pressure high, acid reflux and seasonal allergies. Concomitant medications included calcium citrate (CITRACAL), hydrochlorothiazide (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3); all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206), via an unspecified route of administration in the right arm on 21Mar2021 at 11:45 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and tetracycline (MANUFACTURER UNKNOWN); both on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 15:00, the patient experienced headache, nausea, muscle aches, chills, tiredness, joint pain and injection site pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of headache, nausea, muscle aches, chills, tiredness, joint pain and injection site pain were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: Never been in as much pain in muscles and joints to the point where was unable to walk or use hands; Never been in as much pain in muscles and joints to the point where was unable to walk or use hands; Headaches; This is a spontaneous report from a contactable consumer, the patient. A 71-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 30Mar2021 at 10:15 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high (HBP), COPD, plantar fasciitis and arthritic knees. The patient had no known allergies to medications, food, or other products. Concomitant medications included unspecified blood pressure meds from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809) via an unspecified route of administration in the left arm on 09Mar2021 (at the age of 71-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 11:00, the patient reported that he never had been in as much pain in muscles and joints to the point where the patient was unable to walk or use hands, the patient was still feeling the effects of the second shot. Now the patient had headaches, it stops for a day and starts again. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events pain in muscles and joints to the point where the patient was unable to walk or use hands and headache were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Erythema, Feeling hot, Headache, Peripheral swelling
Clinical narrative: my arm swelled up greatly; turned bright red; very hot; 101 degree fever; terrible headache.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogrens syndrome, raynauds disease and pre-diabetic. The patient had unspecified allergies to food, medication or other products. The patient received unspecified other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 12:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On Thursday, 08Apr2021 at 13:00, the patient arm swelled up greatly, turned bright red and was very hot. She began running a 101degree fever and had a terrible headache. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with methelprednisolone dose pack of steroids. On 08Apr2021, patient body temperature was measured and the result was 101degree (units unspecified). The clinical outcomes of the events arm swelled up greatly, turned bright red and was very hot,101degree fever and terrible headache were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: my arm swelled up greatly; turned bright red; very hot; 101 degree fever; terrible headache.; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogrens syndrome, raynauds disease and pre-diabetic. The patient had unspecified allergies to food, medication or other products. The patient received unspecified other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Mar2021 at 12:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On Thursday, 08Apr2021 at 13:00, the patient arm swelled up greatly, turned bright red and was very hot. She began running a 101degree fever and had a terrible headache. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with methelprednisolone dose pack of steroids. On 08Apr2021, patient body temperature was measured and the result was 101degree (units unspecified). The clinical outcomes of the events arm swelled up greatly, turned bright red and was very hot,101degree fever and terrible headache were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash erythematous, Rash papular, Skin warm
Clinical narrative: Rash with raised red bumps mostly on arms and hands. Starting to appear on neck and lower limbs.; Rash with raised red bumps mostly on arms and hands. Starting to appear on neck and lower limbs.; Itches; Warm; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 31Mar2021 at 17:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included Chronic obstructive pulmonary disease (COPD), Degenerative Disc Disease (DDD), blood pressure high, osteoarthritis, fibromyalgia, asthma, scoliosis, sliding hiatal hernia, Obsessive-Compulsive Disorder (OCD), Attention Deficit Disorder (ADD), apnea, anxiety, migraine, migraines, sciatica, insomnia, depression and fuchs' corneal dystrophy. The patient was not allergic to medications, food, or other products. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate extended release (ADDERALL), oxycodone (MANUFACTURER UNKNOWN), methocarbamol (ROBAXIN), triamterene and esomeprazole sodium (NEXIUM). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN6208) via an unspecified route of administration in the left arm on 08Mar2021 at 17:30 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced rash with raised red bumps mostly on arms and hands which started to appear on neck and lower limbs, itches and warm. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events rash with raised red bumps mostly on arms and hands which started to appear on neck and lower limbs, itches and warm was not resolved.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Adnexa uteri pain, Pain, Pain in extremity, Uterine pain
Clinical narrative: Sore arm as expected; Sore ovaries unclear exactly, but feels like same position as ovaries (i.e. on both sides of uterus); Sore uterus; Low ache, feels a bit like the aches/; Cramps I might get during the early days of my period (but my period finished last week, so can't be that); Pain woke me in the night. Has lasted the last 12 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the arm left on 13Apr2021 at 11:15 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma as a child. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 21:30, the patient experienced sore arm as expected. Sore ovaries or uterus, unclear exactly, but feels like same position as ovaries (i.e. on both sides of uterus). Low ache, feels a bit like the aches/cramps she might get during the early days of her period (but her period finished last week, so can't be that). Pain woke her in the night, has lasted for 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events pain in arm, ovarian pain, uterine pain, ache and abdominal cramp was not recovered however the clinical outcome of the event pain was recovered after a duration of 12 hours.  No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Nasal congestion
Clinical narrative: Cough; chest congestion; Nasal congestion; This is a spontaneous report from a contactable healthcare professional, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: AW0151) via an unspecified route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 23-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunization. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 22:00, the patient experienced cough, chest congestion and nasal congestion. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events cough, chest congestion and nasal congestion were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: painful Hives from head to toe; low grade fever; This is a spontaneous report from a contactable consumer, the patient. A 43-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 15:00 (at the age of 43-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic hives/ cause unknown. Concomitant medications included fexofenadine hydrochloride (ALLEGRA) and cetirizine hydrochloride (ZYRTEC); both for unspecified indication from unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The information on known allergies to medications, food or other products was not applicable. On 08Apr2021 at 11:00,  after the 20 hours mark from the initial vaccine, the patient started breaking out with painful hives from head to toe and did run a low grade fever. The patient could breathe so there was no need to go to the hospital. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event painful hives from head to toe and did run a low grade fever was recovered on an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chest discomfort, Discomfort, Lymphadenopathy
Clinical narrative: Pain under left arm in Armpit area; left chest was really hot; lots of discomfort; lymph node was swollen; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included unspecified birth control medications from unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 09:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 08:00, the patient experienced pain under left arm in armpit area, lymph node was swollen, left chest was really hot and lots of discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain under left arm in armpit area,  lymph node was swollen, left chest was really hot and lots of discomfort was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cough, Eye pain, Headache, Muscle twitching
Clinical narrative: Extreme Hunger stomach pains; Headache; Eye ache; Facial twitching; Leg pain; Cough; Slight wheeze; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Apr2021 at 15:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy, penicillin allergy and allergy to chemicals (silfur). Concomitant medications included levothyroxine sodium (TIROSINT) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); both from unknown dates for unspecified indications. The patient previously took ceftriaxone sodium (ROCEPHIN) on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 16:15, the patient experienced extreme hunger stomach pains, headache, eye ache, facial twitching, leg pains, cough and slight wheeze. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme hunger stomach pains, headache, eye ache, facial twitching, leg pains, cough and slight wheeze were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Wheezing
Clinical narrative: Extreme Hunger stomach pains; Headache; Eye ache; Facial twitching; Leg pain; Cough; Slight wheeze; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Apr2021 at 15:30 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy, penicillin allergy and allergy to chemicals (silfur). Concomitant medications included levothyroxine sodium (TIROSINT) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); both from unknown dates for unspecified indications. The patient previously took ceftriaxone sodium (ROCEPHIN) on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 16:15, the patient experienced extreme hunger stomach pains, headache, eye ache, facial twitching, leg pains, cough and slight wheeze. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme hunger stomach pains, headache, eye ache, facial twitching, leg pains, cough and slight wheeze were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Swelling face
Clinical narrative: Numbness on the left side of face; Swelling on the left side of face.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the right arm on 18Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included obesity and High Blood Pressure (HBP). The patient was allergic to bee, hornets and wasp stings. Concomitant medications included losartan potassium (LOSARTIN), paroxetine hydrochloride (PAROXETINE), hydrochlorothiazide (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809) via an unspecified route of administration in the left arm on 25Feb2021 at 15:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021, the patient experienced swelling and numbness on the left side of face. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swelling and numbness on the left side of face was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles infection; This is a spontaneous report from a contactable healthcare professional. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the arm right on 01Apr2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder and COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), lamotrigine (LAMICTAL), trazodone (MANUFACTURER UNKNOWN) and lithium (MANUFACTURER UNKNOWN) from an unknown date and for unknown indications. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, the patient experienced shingles infection. The patient reported that she had shingles infection 2 weeks following vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles infection and included treatment with VALTREX from an unspecified date in Apr2021 and unknown if ongoing. The clinical outcome of the event shingles infection was not recovered at the time of this report.  No follow up attempts are required; Information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Slightly sore arm; This is a spontaneous report from a non-contactable consumer. A male patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 13Apr2021, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  It was unknown whether the patient received any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced slightly sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event slightly sore arm was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pyrexia
Clinical narrative: Fever 100F; Chills; Headache; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 13Apr2021 at 09:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic rhinitis from an unknown date and unknown if ongoing. Concomitant medications included calcium carbonate; colecalciferol (CALTRATE 600-D), cetirizine hydrochloride (ZYRTEC) and unspecified vitamins once a day; all taken for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 23Mar2021 at 12:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. The patient previously received aspirin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 22:30, the patient experienced fever 100 Fahrenheit, chills and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of events fever 100 Fahrenheit, chills, headache and included treatment with 2 ibuprofen (MANUFACTUER UNKNOWN). The clinical outcome of the events fever 100 Fahrenheit, chills and headache were resolving.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: Fever; Aches; Headache; Arm pain; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 12Apr2021 at 11:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety, gluten and mold allergy. Concomitant medications included diclofenac (MANUFACTURER UNKNOWN) and cyclobenzaprine (MANUFACTURER UNKNOWN) for unknown indication on unknown date and unknown if its ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 11:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 21:00, the patient experienced fever, aches, headache, arm pain and exhaustion. No therapeutic measures were taken as a result of adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, aches, headache, arm pain and exhaustion were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: my fingers are little numb/2 or 3 of my fingers are numb/3 of my fingers are going numb; arm is sore; arm is hurt/pain in my arm; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number and expiration date unknown), via an unspecified route of administration in left Arm on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medication were not reported. Patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunisation. On an unspecified date patient that i had my Pfizer vaccine the second dose, my arm is sore and my fingers are little numb and my arm is hurt from the Pfizer vaccine and my fingers are like numb." Consumer stated, "2 or 3 of my fingers are numb." Consumer stated that "My left arm I got the COVID vaccine twice but now my arm is painful 24 hours a day and it has been 2 weeks and 3 of my fingers are going numb." The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities
Clinical narrative: "can't lift my left arm where vaccine was injected".; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 49-year-old) as a single dose for COVID-19 immunisation. Medical history included shellfish allergy, hay fever and medical tape allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to COVID vaccine. Concomitant medications were not reported. On 13Apr2021 at 13:30, the patient reported that can't lift her left arm where vaccine was injected. The adverse events resulted in the doctor or other healthcare professional office or clinic visit. Therapeutic measures were taken as a result of the events. It was reported that the patient was scheduled for doctor visit on 14Apr at 14:00 for the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event, can't lift her left arm where vaccine was injected was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Developed Shingles rash; rash; This is a spontaneous report from a contactable healthcare professional. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via intramuscular route of administration in the left arm on 06Apr2021 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. The patient previously received cyanocobalamin (VITAMIN B12) on an unspecified date for an unknown indication and experienced drug allergy. Concomitant medications included levothyroxine sodium (SYNTHROID) from an unknown date for unspecified indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Apr2021 the patient had developed Shingles rash, almost 2 weeks following first dose. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with Valtrex. The clinical outcome of the event Shingles rash were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Headache
Clinical narrative: Headaches(mild, transient) initially moderate/severe; Stomach pain(before/after eating) initially moderate/severe; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0151) via an unspecified route of administration in the left arm on 06Apr2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included obsessive-compulsive disorder (OCD), asthma, depression and sleep apnea and shell fish allergy (possibly mild allergy).Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetylcysteine/sodium molybdate/ selenomethionine (NAC),cod-liver-oil (FISH OIL), selegiline (EMSAM), nicotinic acid (NIACIN) and glucosamine sulfate (GLUCOSAMIN), all for unknown indication from an unknown date taken within 2 weeks of vaccination.  The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EN6199) via an unspecified route of administration in the left arm on 16Mar2021 at 11:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 07Apr2021 at 09:00, the patient experienced headaches (mild, transient) initially moderate/severe and stomach pain (before/after eating) initially moderate/severe. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headaches (mild, transient) initially moderate/severe and stomach pain (before/after eating) initially moderate/severe were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: Slight tenderness at injection sight; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EUA) via an unspecified route of administration in the left arm on 12Apr2021 at 19:45 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, pre-diabetes, allergy, food allergy (many foods and tree). The patient previously received erythromycin (MANUFACTURER UNKNOWN) on an unspecified date for an unknown indication and experienced drug allergy. Concomitant medications included metformin (MANUFACTURER UNKNOWN), xylometazoline hydrochloride (SUDAFED), acetylsalicylic acid (ASPIRIN), levocetirizine dihydrochloride (XYZALL), vitamin-D  nos (VITAMIN D) and LOS for unknown indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 13Apr2021, at 07:00 the patient experienced slight tenderness at injection sight and headache. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the event slight tenderness at injection sight and headache was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Headache, Hyperhidrosis, Nausea
Clinical narrative: Intense headache; All over body pain; Chills; Sweating; Nausea; Chest feels tight; This is a spontaneous report from a contactable healthcare professional, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 17:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 05:00, the patient experienced intense headache, all over body pain, chills, sweating, nausea and chest feels tight. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the events intense headache, all over body pain, chills, sweating, nausea and chest feels tight was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Intense headache; All over body pain; Chills; Sweating; Nausea; Chest feels tight; This is a spontaneous report from a contactable healthcare professional, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 13Apr2021 at 17:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 14Apr2021 at 05:00, the patient experienced intense headache, all over body pain, chills, sweating, nausea and chest feels tight. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the events intense headache, all over body pain, chills, sweating, nausea and chest feels tight was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood test, Burning sensation, Computerised tomogram, Electric shock sensation
Clinical narrative: burning in my extremities, moved up to myback, neck, and head.I can barely tolerated any sun light as I feelburning sensation over my body.; I have been experiencing sensation similar to electricalsensations going thru my body; I was not able to sleep; I am not able to exercise, run, or do a lotactivities that I used to do on my own.My quality of life is diminished.; weakness are still with me daily.; I received my 2nd dose on 01/202/2021, in the next 24-48 hours I began experiencing tingling and burning in my extremities, moved up to myback, neck, and head.; Thesesensations and numbness andweakness are still with me daily.; This is a spontaneous report from a contactable physician. A 54-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) via an unspecified route of administration in the left arm on 20Jan2021(at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included budesonide, formoterol fumarate (SYMBICORT INH) for unknown indication since unknown start date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Dec2020(at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Jan2021, the patient received 2nd dose, in next 24-48 hours the patient began experiencing tingling and burning in extremities. Eventually tingling and burning moved up to the back, neck, and head. The patient was not able to sleep as he had been experiencing sensation similar to electrical sensations going thru in his body. The patient can barely tolerate any sun light as he felt burning sensation over his body. These sensations and numbness and weakness are still present in him daily. The patient was not able to exercise, run, or do a lot activities that he used to do on his own. The patient's quality of life was diminished. The events resulted in doctor or other healthcare professional (number of specialists) office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment with ELAVIL, LYRICA and prednisone (MANUFACTURER UNKNOWN). On an unknown date, the patient underwent MRI (brain/spine), CT scan and blood work, but the results were unspecified. The clinical outcome of event tingling, burning sensation, numbness, weakness, not able to exercise, run, or do a lot activities that he used to do on his own, quality of life was diminished, similar to electrical sensations, not able to sleep was not recovered at the time of this report.  No follow-up attempts are needed; No further information is expected.